Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
×
Sign up to our newsletter Click Here
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) (100µg) (Special Terms Apply*)

X

We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help

SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) (100µg) (Special Terms Apply*) (QTXAG-715-100) is SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. The 501.V2 variant, also known as 501.V2, 20H/501Y.V2 (formerly 20C/501Y.V2), was first detected in South Africa.

Product Brand:
Product Code: QTXAG-715-100
Description

SARS-CoV-2 (501.V2) stabilized spike glycoprotein, from the South Africa variant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

*Special Terms: Please see product specification details below and our Ordering page for details.

Product Specification
Specification Type
Specification Value
Product Range
Product Code
QTXAG-715-100
Product Name
SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) (100µg) (Special Terms Apply*)
Product Category
Product Brand
Product Analyte or Application
Product Size
1 x 100 µg
Product Special Terms
Q-TOX Term 1: Shipped Frozen on Dry Ice. Additional Shipping Charge for Dry Ice & Freight Fee Applies
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
Product Storage
Long Term: -80°C or below,Short Term: -80°C or below

Our Accreditations

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.